Meng F - Search Results

1

TGF-β1 promotes colorectal cancer immune escape by elevating B7-H3 and B7-H4 via the miR-155/miR-143 axis.

Zhou X, Mao Y, Zhu J, Meng F, Chen Q, Tao L, Li R, Fu F, Liu C, Hu Y, Wang W, Zhang H, Hua D, Chen W, Zhang X. Zhou X, et al. Among authors: meng f. Oncotarget. 2016 Oct 11;7(41):67196-67211. doi: 10.18632/oncotarget.11950. Oncotarget. 2016. PMID: 27626488 Free PMC article.

2

A polymorphism in the promoter region of PD-L1 serves as a binding-site for SP1 and is associated with PD-L1 overexpression and increased occurrence of gastric cancer.

Tao LH, Zhou XR, Li FC, Chen Q, Meng FY, Mao Y, Li R, Hua D, Zhang HJ, Wang WP, Chen WC. Tao LH, et al. Cancer Immunol Immunother. 2017 Mar;66(3):309-318. doi: 10.1007/s00262-016-1936-0. Epub 2016 Nov 26. Cancer Immunol Immunother. 2017. PMID: 27889799 Free PMC article.

3

A polymorphism in ABCC4 is related to efficacy of 5-FU/capecitabine-based chemotherapy in colorectal cancer patients.

Chen Q, Meng F, Wang L, Mao Y, Zhou H, Hua D, Zhang H, Wang W. Chen Q, et al. Among authors: meng f. Sci Rep. 2017 Aug 1;7(1):7059. doi: 10.1038/s41598-017-07491-3. Sci Rep. 2017. PMID: 28765596 Free PMC article.

4

Rs7911488 modified the efficacy of capecitabine-based therapy in colon cancer through altering miR-1307-3p and TYMS expression.

Chen Q, Mao Y, Meng F, Wang L, Zhang H, Wang W, Hua D. Chen Q, et al. Among authors: meng f. Oncotarget. 2017 Jul 28;8(43):74312-74319. doi: 10.18632/oncotarget.19670. eCollection 2017 Sep 26. Oncotarget. 2017. PMID: 29088787 Free PMC article.

5

The SNPs in pre-miRNA are related to the response of capecitabine-based therapy in advanced colon cancer patients.

Mao Y, Zou C, Meng F, Kong J, Wang W, Hua D. Mao Y, et al. Among authors: meng f. Oncotarget. 2017 Dec 11;9(6):6793-6799. doi: 10.18632/oncotarget.23190. eCollection 2018 Jan 23. Oncotarget. 2017. PMID: 29467929 Free PMC article.

6

Polymorphisms in the ICOS/CD28-ICOSL pathway are related to capecitabine-based chemotherapy response in advanced colon cancer patients.

Mao Y, Wang C, Meng F, Kong J, Cao S, Jiang Y, Wang W, Hua D. Mao Y, et al. Among authors: meng f. Mol Immunol. 2018 Apr;96:78-82. doi: 10.1016/j.molimm.2018.02.017. Epub 2018 Mar 5. Mol Immunol. 2018. PMID: 29505962

7

B7-H3 is spliced by SRSF3 in colorectal cancer.

Zhang C, Chen Y, Li F, Yang M, Meng F, Zhang Y, Chen W, Wang W. Zhang C, et al. Among authors: meng f. Cancer Immunol Immunother. 2021 Feb;70(2):311-321. doi: 10.1007/s00262-020-02683-9. Epub 2020 Jul 27. Cancer Immunol Immunother. 2021. PMID: 32719950 Free PMC article.

8

The rs7911488-T allele promotes the growth and metastasis of colorectal cancer through modulating miR-1307/PRRX1.

Yang M, Liu X, Meng F, Zhang Y, Wang M, Chen Y, Guo X, Chen W, Wang W. Yang M, et al. Among authors: meng f. Cell Death Dis. 2020 Aug 7;11(8):651. doi: 10.1038/s41419-020-02834-x. Cell Death Dis. 2020. PMID: 32811812 Free PMC article.

9

miR-34a induces immunosuppression in colorectal carcinoma through modulating a SIRT1/NF-κB/B7-H3/TNF-α axis.

Meng F, Yang M, Chen Y, Chen W, Wang W. Meng F, et al. Cancer Immunol Immunother. 2021 Aug;70(8):2247-2259. doi: 10.1007/s00262-021-02862-2. Epub 2021 Jan 25. Cancer Immunol Immunother. 2021. PMID: 33492448 Free PMC article.

10

Concomitant inhibition of B7-H3 and PD-L1 expression by a novel and synthetic microRNA delivers potent antitumor activities in colorectal tumor models.

Meng F, Chen Y, Yang M, Zhang H, Wang W. Meng F, et al. Invest New Drugs. 2021 Oct;39(5):1267-1274. doi: 10.1007/s10637-021-01123-4. Epub 2021 Apr 28. Invest New Drugs. 2021. PMID: 33909231

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,101 results

Search Page

Filters